TELADOC HEALTH, INC. Payments to Acquire Available-for-sale Securities
TELADOC HEALTH, INC. (TDOC) reported Payments to Acquire Available-for-sale Securities of $56.35 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2019-02-27
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for the quarter ending 2018-12-31 was $44.21M, a 49.39% increase year-over-year.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $29.59M.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for the quarter ending 2017-09-30 was $84.72M.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for fiscal 2018 was $56.35M, a 62.25% decline from fiscal 2017.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for fiscal 2017 was $149.26M, a 238.11% increase from fiscal 2016.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for fiscal 2016 was $44.15M, a 57.15% decline from fiscal 2015.
- TELADOC HEALTH, INC. payments to acquire available-for-sale securities for fiscal 2015 was $103.03M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-12-31 | $44.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $44.21M derived: sum of 2 quarters · filed 2019-02-27 | $56.35M 10-K · filed 2019-02-27 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $12.14M 10-Q · filed 2018-11-01 | ||
| 2018-06-30 | $12.14M 10-Q · filed 2018-08-01 | |||
| 2017-12-31 | $29.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $114.31M derived: sum of 2 quarters · filed 2019-02-27 | $114.30M derived: sum of 3 quarters · filed 2019-02-27 | $149.26M 10-K · filed 2019-02-27 |
| 2017-09-30 | $84.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $84.71M derived: sum of 2 quarters · filed 2018-11-01 | $119.67M 10-Q · filed 2018-11-01 | $119.63M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $34.95M 10-Q · filed 2018-08-01 | $34.91M derived: sum of 3 quarters · filed 2019-02-27 | $34.91M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $34.96M 10-Q · filed 2018-05-01 | $34.92M derived: sum of 2 quarters · filed 2019-02-27 | $34.91M derived: sum of 3 quarters · filed 2019-02-27 | $41.98M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$42.00K derived: sum of 2 quarters · filed 2019-02-27 | $7.02M derived: sum of 3 quarters · filed 2019-02-27 | $44.15M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $7.07M derived: sum of 2 quarters · filed 2017-11-01 | $44.19M 10-Q · filed 2017-11-01 | $46.66M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $7.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $44.19M 10-Q · filed 2017-08-02 | $46.66M derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $37.12M 10-Q · filed 2017-05-08 | $39.60M derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $103.03M 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $100.56M 10-Q · filed 2016-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |